Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer

Jin Wen,1,&ast; Tingkai Yang,1,&ast; Nora Mallouk,2 Yang Zhang,3 Hanzhong Li,1 Claude Lambert,4 Guorong Li5 1Department of Urology, Peking Union Medical College Hospital, Beijing, People’s Republic of China; 2Center of Electronic Microscopy, CMES, Faculty of Medicine, University Jean Monnet,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wen J, Yang T, Mallouk N, Zhang Y, Li H, Lambert C, Li G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	urinary bladder cancer urinary exosome ca9 liquid biopsy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f8641ec4e52d499b9dc4145ffa1ed4fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f8641ec4e52d499b9dc4145ffa1ed4fa
record_format	dspace
spelling	oai:doaj.org-article:f8641ec4e52d499b9dc4145ffa1ed4fa2021-12-02T14:47:26ZUrinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer1178-2013https://doaj.org/article/f8641ec4e52d499b9dc4145ffa1ed4fa2021-07-01T00:00:00Zhttps://www.dovepress.com/urinary-exosomal-ca9-mrna-as-a-novel-liquid-biopsy-for-molecular-diagn-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Jin Wen,1,&ast; Tingkai Yang,1,&ast; Nora Mallouk,2 Yang Zhang,3 Hanzhong Li,1 Claude Lambert,4 Guorong Li5 1Department of Urology, Peking Union Medical College Hospital, Beijing, People’s Republic of China; 2Center of Electronic Microscopy, CMES, Faculty of Medicine, University Jean Monnet, Saint-Etienne, France; 3Department of Molecular Biology, Guangzhou HopeTech Biological Technology Co, LTD, Guangzhou, People’s Republic of China; 4Unit of Flow Cytometry, Immunology Laboratory, North Hospital, CHU Saint-Etienne, Saint-Etienne, France; 5Department of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France&ast;These authors contributed equally to this workCorrespondence: Hanzhong LiDepartment of Urology, Peking Union Medical College Hospital, Beijing, People’s Republic of ChinaEmail lhzjxmc@163.comGuorong LiDepartment of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, FranceTel +33 477828814Email grli2001@yahoo.frObjective: The objective of this study was to assess the possibility of using urinary exosomal CA9 mRNA as a novel liquid biopsy for the molecular diagnosis of bladder cancer.Patients and Methods: A total of 168 bladder cancer patients and 90 control subjects were included in the study. An isolation kit was used to isolate urinary exosomes. Transmission electron microscopy (TEM) was used to examine the presence of exosomes. Flow cytometry was used to examine the exosomal marker CD63. The expression level of exosomal CA9 mRNA was detected by RT-qPCR. The diagnostic performance of urinary urinary exosomal CA9 mRNA was evaluated.Results: TEM confirmed the enriched exosomes from urinary bladder patients. Flow cytometry indicated a strong positive expression of exosome marker CD63. Successful extraction of RNA was performed from exosome samples. The level of urinary exosomal CA9 mRNA was significantly higher in bladder cancer group than in control group (p< 0.001). The area under the ROC curve was 0.837 (95% CI: 0.743– 0.859) with a sensitivity of 85.18% and a specificity of 83.15% for the diagnosis of bladder cancer.Conclusion: We found that the urinary exosomes were abundant in the urine of bladder cancer patients. CA9 mRNA could be detectable in urinary exosomes. The urinary exosomal CA9 mRNA may present a new liquid biopsy for the diagnosis of bladder cancer.Keywords: urinary bladder cancer, urinary exosome, CA9, liquid biopsyWen JYang TMallouk NZhang YLi HLambert CLi GDove Medical Pressarticleurinary bladder cancerurinary exosomeca9liquid biopsyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 4805-4811 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	urinary bladder cancer urinary exosome ca9 liquid biopsy Medicine (General) R5-920
spellingShingle	urinary bladder cancer urinary exosome ca9 liquid biopsy Medicine (General) R5-920 Wen J Yang T Mallouk N Zhang Y Li H Lambert C Li G Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
description	Jin Wen,1,&ast; Tingkai Yang,1,&ast; Nora Mallouk,2 Yang Zhang,3 Hanzhong Li,1 Claude Lambert,4 Guorong Li5 1Department of Urology, Peking Union Medical College Hospital, Beijing, People’s Republic of China; 2Center of Electronic Microscopy, CMES, Faculty of Medicine, University Jean Monnet, Saint-Etienne, France; 3Department of Molecular Biology, Guangzhou HopeTech Biological Technology Co, LTD, Guangzhou, People’s Republic of China; 4Unit of Flow Cytometry, Immunology Laboratory, North Hospital, CHU Saint-Etienne, Saint-Etienne, France; 5Department of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France&ast;These authors contributed equally to this workCorrespondence: Hanzhong LiDepartment of Urology, Peking Union Medical College Hospital, Beijing, People’s Republic of ChinaEmail lhzjxmc@163.comGuorong LiDepartment of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, FranceTel +33 477828814Email grli2001@yahoo.frObjective: The objective of this study was to assess the possibility of using urinary exosomal CA9 mRNA as a novel liquid biopsy for the molecular diagnosis of bladder cancer.Patients and Methods: A total of 168 bladder cancer patients and 90 control subjects were included in the study. An isolation kit was used to isolate urinary exosomes. Transmission electron microscopy (TEM) was used to examine the presence of exosomes. Flow cytometry was used to examine the exosomal marker CD63. The expression level of exosomal CA9 mRNA was detected by RT-qPCR. The diagnostic performance of urinary urinary exosomal CA9 mRNA was evaluated.Results: TEM confirmed the enriched exosomes from urinary bladder patients. Flow cytometry indicated a strong positive expression of exosome marker CD63. Successful extraction of RNA was performed from exosome samples. The level of urinary exosomal CA9 mRNA was significantly higher in bladder cancer group than in control group (p< 0.001). The area under the ROC curve was 0.837 (95% CI: 0.743– 0.859) with a sensitivity of 85.18% and a specificity of 83.15% for the diagnosis of bladder cancer.Conclusion: We found that the urinary exosomes were abundant in the urine of bladder cancer patients. CA9 mRNA could be detectable in urinary exosomes. The urinary exosomal CA9 mRNA may present a new liquid biopsy for the diagnosis of bladder cancer.Keywords: urinary bladder cancer, urinary exosome, CA9, liquid biopsy
format	article
author	Wen J Yang T Mallouk N Zhang Y Li H Lambert C Li G
author_facet	Wen J Yang T Mallouk N Zhang Y Li H Lambert C Li G
author_sort	Wen J
title	Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
title_short	Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
title_full	Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
title_fullStr	Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
title_full_unstemmed	Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
title_sort	urinary exosomal ca9 mrna as a novel liquid biopsy for molecular diagnosis of bladder cancer
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/f8641ec4e52d499b9dc4145ffa1ed4fa
work_keys_str_mv	AT wenj urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT yangt urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT malloukn urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT zhangy urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT lih urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT lambertc urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer AT lig urinaryexosomalca9mrnaasanovelliquidbiopsyformoleculardiagnosisofbladdercancer
_version_	1718389545469214720

Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer

Ejemplares similares